4//SEC Filing
BALLIET JENNIFER 4
Accession 0001077183-19-000212
CIK 0001077183other
Filed
Nov 17, 7:00 PM ET
Accepted
Nov 18, 12:30 PM ET
Size
13.2 KB
Accession
0001077183-19-000212
Insider Transaction Report
Form 4
BALLIET JENNIFER
Vice President of HR
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2019-11-15−6,667→ 20,000 totalExercise: $7.52From: 2018-04-28Exp: 2022-04-28→ Common Stock (6,667 underlying) - Exercise/Conversion
Common Stock
2019-11-15$8.03/sh+166$1,333→ 29,695 total - Exercise/Conversion
Stock Option (Right to Buy)
2019-11-15−166→ 48,334 totalExercise: $8.03From: 2019-02-26Exp: 2023-02-26→ Common Stock (166 underlying) - Exercise/Conversion
Common Stock
2019-11-15$7.52/sh+6,667$50,136→ 29,529 total - Sale
Common Stock
2019-11-15$23.45/sh−6,833$160,234→ 22,862 total
Holdings
- 17,496
Stock Option (Right to Buy)
Exercise: $19.60From: 2020-03-01Exp: 2024-03-01→ Common Stock (17,496 underlying)
Footnotes (3)
- [F1]On April 28, 2017, Jennifer Balliet was granted 60,000 stock options which vest ratably over the first three anniversary dates of the grant date.
- [F2]On February 26, 2018, Jennifer Balliet was granted 72,500 stock options which vest ratably over the first three anniversary dates of the grant date.
- [F3]On March 1, 2019, Jennifer Balliet was granted 17,496 stock options which vest ratably over the first four anniversary dates of the grant date.
Documents
Issuer
NEOGENOMICS INC
CIK 0001077183
Entity typeother
Related Parties
1- filerCIK 0001640500
Filing Metadata
- Form type
- 4
- Filed
- Nov 17, 7:00 PM ET
- Accepted
- Nov 18, 12:30 PM ET
- Size
- 13.2 KB